{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:20:19Z","timestamp":1790698819174,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.vaccine.2012.11.035","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T12:41:04Z","timestamp":1366202464000},"page":"B61-B72","source":"Crossref","is-referenced-by-count":123,"special_numbering":"S2","title":["The estimated mortality impact of vaccinations forecast to be administered during 2011\u20132020 in 73 countries supported by the GAVI Alliance"],"prefix":"10.1016","volume":"31","author":[{"given":"Lisa A.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Franzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Atwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Deblina","family":"Datta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid K.","family":"Friberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue J.","family":"Goldie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Reef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Schwalbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Strebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutima","family":"Suraratdecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Tam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Vynnycky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neff","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian G.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2012.11.035_bib0005","series-title":"Unpublished presentation at the GAVI Board Meeting","article-title":"GAVI vaccine portfolio metrics analysis. Input assumptions \u2013 board paper case","author":"Applied Strategies","year":"2009"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0010","series-title":"Forecasting the impact of GAVI Alliance vaccine support using the long range cost and impact model: methods and limitations","author":"Lee","year":"2011"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0015","series-title":"World population prospects, the 2010 revision","author":"United Nations, Department of Economic and Social Affairs, Population Division","year":"2010"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0410","doi-asserted-by":"crossref","first-page":"B5","DOI":"10.1016\/j.vaccine.2013.02.015","article-title":"Global Vaccine Action Plan","volume":"31","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0025","series-title":"Immunization summary","author":"World Health Organization and United Nations Children's Fund","year":"2012"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0030","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/ije\/dyi206","article-title":"A mathematical model to estimate global hepatitis B disease burden and vaccination impact","volume":"34","author":"Goldstein","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.11.035_bib0035","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1186\/1471-2458-11-S3-S32","article-title":"Methods used in the Lives Saved Tool (LiST)","volume":"11","author":"Winfrey","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0040","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0140-6736(09)61203-4","article-title":"Burden of disease caused by Haemophilus influenzae type b in children younger than 5 years: global estimates","volume":"374","author":"Watt","year":"2009","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.11.035_bib0045","doi-asserted-by":"crossref","first-page":"i172","DOI":"10.1093\/ije\/dyq033","article-title":"The effect of Haemophilus influenzae type b and pneumococcal conjugate vaccines on childhood pneumonia incidence, severe morbidity and mortality","volume":"39","author":"Theodoratou","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0050","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","article-title":"Global, regional, and national causes of child mortality in 2008: a systematic analysis","volume":"375","author":"Black","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0055","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1093\/ije\/dyg241","article-title":"Predicting the distribution of under-five deaths by cause in countries without adequate vital registration systems","volume":"32","author":"Morris","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0060","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O\u2019Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0065","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2471\/BLT.07.050054","article-title":"Estimating child mortality due to diarrhoea in developing countries","volume":"86","author":"Boschi-Pinto","year":"2008","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0070","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3201\/eid1202.050006","article-title":"Rotavirus and severe childhood diarrhea","volume":"12","author":"Parashar","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"Suppl. 3","key":"10.1016\/j.vaccine.2012.11.035_bib0075","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1186\/1471-2458-11-S3-S16","article-title":"Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size","volume":"11","author":"Fischer Walker","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa0905211","article-title":"Effect of rotavirus vaccination on death from childhood diarrhea in Mexico","volume":"362","author":"Richardson","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0085","doi-asserted-by":"crossref","first-page":"e1001024","DOI":"10.1371\/journal.pmed.1001024","article-title":"Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis","volume":"8","author":"do Carmo","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0090","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1016\/j.vaccine.2008.04.053","article-title":"Health and economic outcomes of HPV 16,18 vaccination in 72 GAVI-eligible countries","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0095","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/aje\/kwm086","article-title":"Multiparameter calibration of a natural history model of cervical cancer","volume":"166","author":"Kim","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0100","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1016\/j.vaccine.2007.05.058","article-title":"Cost-effectiveness of HPV 16 18 vaccination in Brazil","volume":"25","author":"Goldie","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0105","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/sj.bjc.6604023","article-title":"The value of including boys in an HPV vaccination programme: a cost-effectiveness analysis in a low-resource setting","volume":"97","author":"Kim","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0110","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0115","doi-asserted-by":"crossref","first-page":"L59","DOI":"10.1016\/j.vaccine.2008.05.063","article-title":"Mathematical models of cervical cancer prevention in Latin America and the Caribbean","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0120","doi-asserted-by":"crossref","first-page":"M17","DOI":"10.1016\/j.vaccine.2008.06.018","article-title":"Mathematical models of cervical cancer prevention in the Asia Pacific region","volume":"26","author":"Goldie","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0125","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/ijc.26269","article-title":"Health and economic impact of HPV 16\/18 vaccination and cervical cancer screening in Eastern Africa","volume":"130","author":"Campos","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0130","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.bjc.6604462","article-title":"Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India","volume":"99","author":"Diaz","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0135","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2165\/00019053-200826030-00004","article-title":"Cost-effectiveness analyses of vaccination programmes: a focused review of modelling approaches","volume":"26","author":"Kim","year":"2008","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0140","series-title":"GLOBOCAN 2008, Cancer incidence and mortality worldwide. IARC Cancer Base No. 10 [Internet]","author":"Ferlay","year":"2010"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0145","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0150","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1371\/journal.pmed.0050132","article-title":"Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities","volume":"5","author":"Gakidou","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0155","series-title":"SEER cancer statistics review, 1975\u20132009 (vintage 2009 populations)","author":"Howlader","year":"2009"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0160","doi-asserted-by":"crossref","first-page":"274","DOI":"10.4269\/ajtmh.1993.48.274","article-title":"Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria","volume":"2","author":"Monath","year":"1993","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0165","series-title":"Eliminating serogroup A meningococcal meningitis epidemics as a public health problem in Africa. An investment case for the GAVI Alliance","author":"World Health Organization and United Nations Children's Fund","year":"2008"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0170","first-page":"499","article-title":"Epidemiology of bacterial meningitis in Niamey, Niger, 1981\u201396","volume":"77","author":"Campagne","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0175","doi-asserted-by":"crossref","first-page":"4593","DOI":"10.1016\/j.vaccine.2010.04.086","article-title":"A cost-effectiveness analysis of Japanese encephalitis vaccine in Cambodia","volume":"28","author":"Touch","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1300\/J371v15n01_05","article-title":"A cost-effectiveness analysis of strategies for controlling Japanese encephalitis in Andhra Pradesh, India","volume":"15","author":"Suraratdecha","year":"2006","journal-title":"J Pharm Finance Econ Pol"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0185","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.vaccine.2012.11.035_bib0190","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1741-7015-4-8","article-title":"A hospital-based surveillance for Japanese encephalitis in Bali, Indonesia","volume":"7","author":"Kari","year":"2006","journal-title":"BMC Med"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0195","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3201\/eid0601.000103","article-title":"Japanese encephalitis immunization in South Korea: past present and future","volume":"6","author":"Sohn","year":"2000","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0200","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0205","doi-asserted-by":"crossref","first-page":"5041","DOI":"10.1016\/j.vaccine.2007.04.052","article-title":"Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case\u2013control study in Nepalese children 5 years after immunization","volume":"25","author":"Tandan","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0210","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/ije\/28.6.1176","article-title":"Modelling the incidence of congenital rubella syndrome in developing countries","volume":"28","author":"Cutts","year":"1999","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0215","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1016\/S0264-410X(03)00229-9","article-title":"The predicted impact of private sector MMR vaccination on the burden of congenital rubella syndrome","volume":"21","author":"Vynnycky","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0220","series-title":"Markov chain Monte Carlo in practice","author":"Gilks","year":"1995"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0225","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(82)92677-0","article-title":"Consequences of confirmed maternal rubella at successive stages of pregnancy","volume":"2","author":"Miller","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0230","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1016\/j.vaccine.2006.05.089","article-title":"Costs of congenital rubella syndrome (CRS) in Oman: evidence based on long-term follow-up of 43 children","volume":"24","author":"Al-Awaidy","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0235","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.2105\/AJPH.90.10.1555","article-title":"Unseen blindness, unheard deafness, and unrecorded death and disability: congenital rubella in Kumasi Ghana","volume":"90","author":"Lawn","year":"2000","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0240","first-page":"110","article-title":"Rubella in Panama: still a problem","volume":"8","author":"Saad de Owens","year":"1989","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0245","first-page":"415","article-title":"Impact of rubella vaccination strategy on the occurrence of congenital rubella syndrome","volume":"83","author":"Lanzieri","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0250","first-page":"117","article-title":"Tracking measles infection through non-linear state space models","volume":"61","author":"Chen","year":"2012","journal-title":"Appl Stat"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0255","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(12)60522-4","article-title":"Assessment of the 2010 global measles mortality reduction goal: results from a model of surveillance data","volume":"379","author":"Simons","year":"2012","journal-title":"Lancet"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.11.035_bib0260","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1086\/368114","article-title":"The global burden of measles in the year 2000\u2014a model that uses country-specific indicators","volume":"187","author":"Stein","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.11.035_bib0265","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1093\/infdis\/jir102","article-title":"Field effectiveness of live attenuated measles-containing vaccines: a review of published literature","volume":"204","author":"Uzicanin","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0270","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ije\/dyn224","article-title":"Estimates of measles case fatality ratios: a comprehensive review of community-based studies","volume":"38","author":"Wolfson","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0275","series-title":"Disease control priorities in developing countries","first-page":"389","article-title":"Vaccine-preventable diseases","author":"Brenzel","year":"2006"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0280","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0285","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0290","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Mai","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0295","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","article-title":"Efficacy and safety of a modified killed whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised double-blind, placebo-controlled trial","volume":"374","author":"Sur","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0300","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0140-6736(96)06107-7","article-title":"Field trial of a locally produced, killed, oral cholera vaccine in Vietnam","volume":"349","author":"Trach","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0305","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS, S\/AS01 malaria vaccine in African children","volume":"365","author":"Agnandji","year":"2011","journal-title":"N Engl J Med"},{"issue":"Suppl. 1","key":"10.1016\/j.vaccine.2012.11.035_bib0310","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/INF.0b013e3181fefa1f","article-title":"Real-world impact of rotavirus vaccination","volume":"30","author":"Patel","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(04)17664-2","article-title":"Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial","volume":"365","author":"Gessner","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0320","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S1473-3099(12)70168-8","article-title":"Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data","volume":"12","author":"Novak","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0325","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(09)60317-2","article-title":"Timing of children's vaccinations in 45 low-income and middle-income countries: an analysis of survey data","volume":"373","author":"Clark","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0330","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/oxfordjournals.epirev.a036023","article-title":"Assessing vaccine efficacy in the field: further observations","volume":"10","author":"Orenstein","year":"1988","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0335","first-page":"353","article-title":"Standardized interpretation of paediatric chest radiographs for the diagnosis of pneumonia in epidemiological studies","volume":"83","author":"Cherian","year":"2005","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0340","first-page":"1","article-title":"Describing the epidemiology and aetiology of bacterial pneumonia in children: an unresolved problem","volume":"23","author":"Cherian","year":"2005","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0345","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/ers.11.47","article-title":"Acute lower respiratory infection in the developing world","volume":"5","author":"Gessner","year":"2011","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0350","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1136\/bmj.329.7474.1096","article-title":"Monitoring global health: time for new solutions","volume":"329","author":"Murray","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0355","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0360","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1473-3099(01)00170-0","article-title":"Estimates of world-wide distribution of child deaths from acute respiratory infections","volume":"2","author":"Williams","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0365","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2471\/BLT.08.059220","article-title":"Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications","volume":"87","author":"Rani","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0370","first-page":"289","article-title":"Evaluation of the impact of hepatitis B vaccine integration into routine immunization in the areas of the Ministry of Health\/Global Alliance for Vaccines and Immunizations (GAVI) Cooperation Project, People's Republic of China","volume":"15","author":"Cui","year":"2009","journal-title":"Zhongguo Yi Miao He Mian Yi"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0375","doi-asserted-by":"crossref","first-page":"252","DOI":"10.4269\/ajtmh.2009.81.252","article-title":"Results from nationwide hepatitis B serosurvey in Cambodia using simple and rapid laboratory test: implications for national immunization program","volume":"81","author":"Soeung","year":"2009","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0380","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1586\/14760584.8.1.91","article-title":"Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa","volume":"8","author":"Gessner","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0385","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1590\/S1020-49892008000900002","article-title":"Impact of Haemophilus influenzae type b conjugate vaccine on bacterial meningitis in the Dominican Republic","volume":"24","author":"Lee","year":"2008","journal-title":"Pan Am J Public Health"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0390","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.coviro.2012.05.002","article-title":"Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011","volume":"2","author":"Lopman","year":"2012","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0395","series-title":"Global measles and rubella strategic plan, 2012\u20132020","author":"World Health Organization","year":"2012"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0400","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1377\/hlthaff.2011.0328","article-title":"Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine","volume":"30","author":"LaForce","year":"2011","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.vaccine.2012.11.035_bib0405","series-title":"Global plan of action for new and under-utilized vaccines implementation: 2010\u20132011","author":"World Health Organization","year":"2010"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X12016283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T05:25:13Z","timestamp":1745990713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X12016283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":81,"alternative-id":["S0264410X12016283"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.11.035","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}